Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Variations in stromal signatures in breast and colorectal cancer metastases.

Webster JA, Beck AH, Sharma M, Espinosa I, Weigelt B, Schreuder M, Montgomery KD, Jensen KC, van de Rijn M, West R.

J Pathol. 2010 Oct;222(2):158-65. doi: 10.1002/path.2738.

2.

Stromal signatures in endometrioid endometrial carcinomas.

Espinosa I, Catasus L, D' Angelo E, Mozos A, Pedrola N, Bértolo C, Ferrer I, Zannoni GF, West RB, van de Rijn M, Matias-Guiu X, Prat J.

Mod Pathol. 2014 Apr;27(4):631-9. doi: 10.1038/modpathol.2013.131. Epub 2013 Nov 22.

3.

Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.

Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB.

Breast Cancer Res Treat. 2010 Sep;123(2):397-404. doi: 10.1007/s10549-009-0654-0. Epub 2009 Dec 1.

4.

Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer.

Guo X, Zhu SX, Brunner AL, van de Rijn M, West RB.

Breast Cancer Res. 2013 Dec 17;15(6):R117. doi: 10.1186/bcr3586.

5.

Stromal responses among common carcinomas correlated with clinicopathologic features.

Chen JL, Espinosa I, Lin AY, Liao OY, van de Rijn M, West RB.

Clin Cancer Res. 2013 Sep 15;19(18):5127-35. doi: 10.1158/1078-0432.CCR-12-3127. Epub 2013 Jun 26.

6.

Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.

Wu JM, Beck AH, Pate LL, Witten D, Zhu SX, Montgomery KD, Allison KH, van de Rijn M, West RB.

Clin Cancer Res. 2011 Feb 1;17(3):437-46. doi: 10.1158/1078-0432.CCR-10-1709. Epub 2010 Nov 22.

7.

Macrophage-colony stimulating factor (CSF1) predicts breast cancer progression and mortality.

Richardsen E, Uglehus RD, Johnsen SH, Busund LT.

Anticancer Res. 2015 Feb;35(2):865-74.

PMID:
25667468
8.

The macrophage colony-stimulating factor 1 response signature in breast carcinoma.

Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M, West RB.

Clin Cancer Res. 2009 Feb 1;15(3):778-87. doi: 10.1158/1078-0432.CCR-08-1283.

9.

The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.

Sjöström-Mattson J, Von Boguslawski K, Bengtsson NO, Mjaaland I, Salmenkivi K, Blomqvist C.

Acta Oncol. 2009;48(8):1137-43. doi: 10.3109/02841860902988688.

PMID:
19863221
10.

The fibromatosis signature defines a robust stromal response in breast carcinoma.

Beck AH, Espinosa I, Gilks CB, van de Rijn M, West RB.

Lab Invest. 2008 Jun;88(6):591-601. doi: 10.1038/labinvest.2008.31. Epub 2008 Apr 14.

11.

Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.

Yamanashi T, Nakanishi Y, Fujii G, Akishima-Fukasawa Y, Moriya Y, Kanai Y, Watanabe M, Hirohashi S.

Oncology. 2009;77(1):53-62. doi: 10.1159/000226112. Epub 2009 Jun 25.

PMID:
19556810
12.

Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer.

Kwon HC, Kim SH, Roh MS, Kim JS, Lee HS, Choi HJ, Jeong JS, Kim HJ, Hwang TH.

Dis Colon Rectum. 2004 Feb;47(2):141-52.

PMID:
15043283
13.

IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.

Rajski M, Zanetti-Dällenbach R, Vogel B, Herrmann R, Rochlitz C, Buess M.

BMC Med. 2010 Jan 5;8:1. doi: 10.1186/1741-7015-8-1.

14.

Cytoplasmic mislocalization of overexpressed FOXF1 is associated with the malignancy and metastasis of colorectal adenocarcinomas.

Lo PK, Lee JS, Chen H, Reisman D, Berger FG, Sukumar S.

Exp Mol Pathol. 2013 Feb;94(1):262-9. doi: 10.1016/j.yexmp.2012.10.014. Epub 2012 Oct 24.

15.

Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage.

Koehler A, Bataille F, Schmid C, Ruemmele P, Waldeck A, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.

J Pathol. 2004 Sep;204(1):65-74.

PMID:
15307139
16.

Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.

Hao X, Sun B, Hu L, Lähdesmäki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, Zhang W.

Cancer. 2004 Mar 15;100(6):1110-22.

17.

A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.

Schmidt M, Hellwig B, Hammad S, Othman A, Lohr M, Chen Z, Boehm D, Gebhard S, Petry I, Lebrecht A, Cadenas C, Marchan R, Stewart JD, Solbach C, Holmberg L, Edlund K, Kultima HG, Rody A, Berglund A, Lambe M, Isaksson A, Botling J, Karn T, Müller V, Gerhold-Ay A, Cotarelo C, Sebastian M, Kronenwett R, Bojar H, Lehr HA, Sahin U, Koelbl H, Gehrmann M, Micke P, Rahnenführer J, Hengstler JG.

Clin Cancer Res. 2012 May 1;18(9):2695-703. doi: 10.1158/1078-0432.CCR-11-2210. Epub 2012 Feb 20.

18.

Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.

D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.

Breast Cancer Res Treat. 2007 Mar;101(3):279-84. Epub 2006 Jul 12.

PMID:
16835704
20.

Supplemental Content

Support Center